Literature DB >> 6315130

Infection with netilmicin resistant Serratia marcescens in a special care baby unit.

D A Lewis, P M Hawkey, D C Speller, R J Primavesi, P J Fleming, T L Pitt.   

Abstract

An outbreak of colonisation and infection with a netilmicin resistant strain of Serratia marcescens occurred in a special care baby unit. S marcescens was isolated from a total of 13 babies; significant infection occurred in five, of whom two died. Epidemiological investigation failed to detect a common source but gastrointestinal colonisation of babies formed a prolonged and possibly important reservoir for infection. Containment proved difficult until the unit was closed to new admissions, and even then spread to a temporary unit ensued. O Serotyping and bacteriophage typing disclosed a single epidemic strain. This produced an aminoglycoside acetylating enzyme (AAC(6')) conferring resistance to netilmicin and tobramycin and moderate resistance to amikacin. Use of gentamicin resulted in the isolation of serratia with increased resistance to all aminoglycosides, and, similarly, increased resistance to third generation cephalosporins emerged with their use.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6315130      PMCID: PMC1550087          DOI: 10.1136/bmj.287.6406.1701

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  19 in total

1.  Isolation of Serratia marcescens on deoxyribonuclease-toluidine blue-cephalothin agar.

Authors:  J J Farmer; F Silva; D R Williams
Journal:  Appl Microbiol       Date:  1973-01

2.  Nosocomial urinary tract infection with Serratia marcescens: an epidemiologic study.

Authors:  D G Maki; C G Hennekens; C W Phillips; W V Shaw; J V Bennett
Journal:  J Infect Dis       Date:  1973-11       Impact factor: 5.226

3.  Control of a single source nursery epidemic due to Serratia marcescens.

Authors:  R C McCormack; C M Kunin
Journal:  Pediatrics       Date:  1966-05       Impact factor: 7.124

4.  Novel resistance selected by the new expanded-spectrum cephalosporins: a concern.

Authors:  C C Sanders
Journal:  J Infect Dis       Date:  1983-03       Impact factor: 5.226

5.  Outbreak of amikacin-resistant Enterobacteriaceae in an intensive care nursery.

Authors:  L N Cook; R S Davis; B H Stover
Journal:  Pediatrics       Date:  1980-02       Impact factor: 7.124

6.  A nursery outbreak caused by Serratia marcescens--scalp-vein needles as a portal of entry.

Authors:  W E Stamm; C A Kolff; E M Dones; R Javariz; R L Anderson; J J Farmer; H R de Quinones
Journal:  J Pediatr       Date:  1976-07       Impact factor: 4.406

7.  Amikacin therapy of patients with multiply antibiotic-resistant Serratia marcescens infections: development of increasing resistance during therapy.

Authors:  P C Craven; J H Jorgensen; R L Kaspar; D J Drutz
Journal:  Am J Med       Date:  1977-06       Impact factor: 4.965

8.  Gentamicin-resistant Pseudomonas aeruginosa and Serratia marcescens in a general hospital.

Authors:  R D Meyer; R P Lewis; J Halter; M White
Journal:  Lancet       Date:  1976-03-13       Impact factor: 79.321

9.  The epidemiological type identification of Serratia marcescens from outbreaks of infection in hospitals.

Authors:  T L Pitt; Y J Erdman; C Bucher
Journal:  J Hyg (Lond)       Date:  1980-04

10.  Detection of Serratia outbreaks in hospital.

Authors:  J J Farmer; B R Davis; F W Hickman; D B Presley; G P Bodey; M Negut; R A Bobo
Journal:  Lancet       Date:  1976-08-28       Impact factor: 79.321

View more
  11 in total

1.  Duodenal microflora in very-low-birth-weight neonates and relation to necrotizing enterocolitis.

Authors:  C M Hoy; C M Wood; P M Hawkey; J W Puntis
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

2.  Pharmacokinetics of aztreonam in very low birthweight neonates.

Authors:  M R Millar; P Gorham; H Baxter; K Flannigan; P Congdon
Journal:  Eur J Clin Microbiol       Date:  1987-12       Impact factor: 3.267

3.  Use of molecular typing to study the epidemiology of Serratia marcescens.

Authors:  A McGeer; D E Low; J Penner; J Ng; C Goldman; A E Simor
Journal:  J Clin Microbiol       Date:  1990-01       Impact factor: 5.948

Review 4.  Serratia infections: from military experiments to current practice.

Authors:  Steven D Mahlen
Journal:  Clin Microbiol Rev       Date:  2011-10       Impact factor: 26.132

5.  Comparison of serotype, biotype and bacteriocin type with rDNA RFLP patterns for the type identification of Serratia marcescens.

Authors:  R Alonso; H M Aucken; J C Perez-Diaz; B D Cookson; F Baquero; T L Pitt
Journal:  Epidemiol Infect       Date:  1993-08       Impact factor: 2.451

6.  Epidemic outbreak of Serratia marcescens infection in a cardiac surgery unit.

Authors:  I Wilhelmi; J C Bernaldo de Quirós; J Romero-Vivas; J Duarte; E Rojo; E Bouza
Journal:  J Clin Microbiol       Date:  1987-07       Impact factor: 5.948

7.  A comparison of ceftazidime and aminoglycoside based regimens as empirical treatment in 1316 cases of suspected sepsis in the newborn. European Society for Paediatric Infectious Diseases--Neonatal Sepsis Study Group.

Authors:  J de Louvois; R Dagan; I Tessin
Journal:  Eur J Pediatr       Date:  1992-12       Impact factor: 3.183

8.  Analysis of epidemiologic markers of nosocomial Serratia marcescens isolates with special reference to the Grimont biotyping system.

Authors:  J Sifuentes-Osornio; G M Ruiz-Palacios; D H Gröschel
Journal:  J Clin Microbiol       Date:  1986-02       Impact factor: 5.948

Review 9.  Netilmicin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Campoli-Richards; S Chaplin; R H Sayce; K L Goa
Journal:  Drugs       Date:  1989-11       Impact factor: 9.546

10.  Increased resistance to amikacin in a neonatal unit following intensive amikacin usage.

Authors:  I R Friedland; E Funk; M Khoosal; K P Klugman
Journal:  Antimicrob Agents Chemother       Date:  1992-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.